Sign in
4

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001493152-20-022256

CHIEF EXECUTIVE OFFICER bought 50,500 shares at $0.19 ($9,595)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Trieu Vuong CHIEF EXECUTIVE OFFICER 2020-11-19 Purchase +50,500 $0.19 $9,595 15,812,308 D: show line 1 in the form
Open-market purchases · 50,500 sh · avg $0.19 · $9,595
Loading xslF345X03/ownership.xml…